MedTrace Logo

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

NCT03792854 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-01-03

No results posted yet for this study

Summary

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer

Conditions

Interventions

OTHER

EORTC QLQ C30

standardized questionaire

OTHER

EORTC QLQ CR29

standardized questionaire

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Falk Roeder, MD · Ludwig-Maximilians Universität München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2021-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03792854 on ClinicalTrials.gov